Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seizure, Partial Onset”

213 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 213 results

Large-scale testing (Phase 3)Study completedNCT03201900
What this trial is testing

Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study)

Who this might be right for
Partial Onset Seizures
Eisai Co., Ltd. 91
Large-scale testing (Phase 3)Study completedNCT00975715
What this trial is testing

Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures

Who this might be right for
Partial Onset Seizures
Novartis Pharmaceuticals 99
Large-scale testing (Phase 3)Study completedNCT05614063
What this trial is testing

Study of XEN1101 Versus Placebo in Focal-Onset Seizures

Who this might be right for
Focal Onset Seizures
Xenon Pharmaceuticals Inc. 380
Post-approval studies (Phase 4)Study completedNCT03288129
What this trial is testing

Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

Who this might be right for
Partial Onset SeizuresSecondarily Generalized SeizuresPrimary Generalized Tonic-Clonic Seizures
Eisai Inc. 54
Testing effectiveness (Phase 2)Study completedNCT00938431
What this trial is testing

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Who this might be right for
Epilepsy
UCB Pharma 47
Large-scale testing (Phase 3)Study completedNCT00152516
What this trial is testing

Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial
UCB Pharma 255
Large-scale testing (Phase 3)Study completedNCT01618695
What this trial is testing

A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures

Who this might be right for
Partial-onset Seizures
Eisai Co., Ltd. 940
Large-scale testing (Phase 3)Study completedNCT01336621
What this trial is testing

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS)

Who this might be right for
Epilepsy
GlaxoSmithKline 98
Not applicableNo Longer AvailableNCT03559673
What this trial is testing

Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic Seizures

Who this might be right for
Epilepsies, Partial
UCB Biopharma S.P.R.L.
Testing effectiveness (Phase 2)Looking for participantsNCT06590896
What this trial is testing

Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

Who this might be right for
Epilepsies, Partial
Ono Pharmaceutical Co., Ltd. 100
Large-scale testing (Phase 3)WithdrawnNCT03108729
What this trial is testing

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

Who this might be right for
Epilepsy
Sumitomo Pharma America, Inc.
Early research (Phase 1)Study completedNCT00426673
What this trial is testing

An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy.

Who this might be right for
Epilepsy
UCB Pharma 15
Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Testing effectiveness (Phase 2)Study completedNCT00152451
What this trial is testing

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial
UCB S.A. - Pharma Sector 31
Testing effectiveness (Phase 2)Study completedNCT01002820
What this trial is testing

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

Who this might be right for
Epilepsy, Complex Partial
Marinus Pharmaceuticals 11
Not applicableStudy completedNCT01830868
What this trial is testing

A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM)

Who this might be right for
Partial Onset Seizures
Eisai Inc. 104
Post-approval studies (Phase 4)Study completedNCT05533814
What this trial is testing

Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures

Who this might be right for
Epilepsy
Eisai Korea Inc. 125
Not applicableStudy completedNCT01830400
What this trial is testing

A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS)

Who this might be right for
Partial Onset Seizures
Eisai Inc. 254
Not applicableStudy completedNCT01457989
What this trial is testing

Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304

Who this might be right for
Epilepsy, Partial
GlaxoSmithKline 1
Large-scale testing (Phase 3)Study completedNCT00772603
What this trial is testing

Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures

Who this might be right for
Epilepsies, Partial
Supernus Pharmaceuticals, Inc. 366
Load More Results